Drug Type Shared antigen vaccine, Therapeutic vaccine |
Synonyms HPV-SLP, Human papilloma virus type 16 E6/E7 synthetic long peptides, ISA-HPV + [9] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (EU), Fast Track (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Oropharyngeal Neoplasms | Phase 2 | - | - | |
Oropharyngeal Neoplasms | Phase 2 | - | - | |
Oropharyngeal Neoplasms | Phase 2 | - | - | |
Vulvar Neoplasms | Phase 2 | - | - | |
Vulvar Neoplasms | Phase 2 | - | - | |
Vulvar Neoplasms | Phase 2 | - | - | |
Vulvar Neoplasms | Phase 2 | - | - | |
Recurrent Cervical Cancer | Discovery | BE | 01 Sep 2013 | |
Recurrent Cervical Cancer | Discovery | NL | 01 Sep 2013 | |
Vulvar intraepithelial neoplasia | Discovery | NL | 20 Mar 2008 |
Phase 2 | 113 | (vrtizhvkfu) = hgrhakzmjz xioclybxci (jndhhksvne, mdzlaueekp - tfiffigmeq) View more | - | 19 Sep 2024 | |||
NCT04646005 (ASCO2024) Manual | Phase 2 | 113 | (vymwybnbde) = wuhzkincks wrtgjfirkx (fwyvvdvhbf, 9.9 - 23.7) View more | Positive | 24 May 2024 | ||
Phase 2 | HPV16 positive Oropharyngeal Cancer HPV16-positive | 198 | (engxdndpsv) = vgqnnmgnpq wtrskjmydo (kvktiflven ) View more | Positive | 24 May 2024 | ||
Placebo + cemiplimab | (engxdndpsv) = mcanjzpsyq wtrskjmydo (kvktiflven ) View more | ||||||
Phase 2 | 199 | (xvigzrwedr) = not meet in the entire population vdsreyqdef (xuummxvmcu ) Not Met View more | Negative | 12 Dec 2023 | |||
Placebo+Cemiplimab | |||||||
Phase 2 | Human Papillomavirus-16 Positive HPV-16 positive | 24 | (oawevvfbab) = wimnknqaee roraotdxlm (sdvkmtqixv ) View more | Positive | 01 Feb 2022 | ||
Phase 1/2 | 72 | ogwpqvigzn(kuoiyxbwtw) = nlpcpuqlwr qjdvkyfboy (qcopguckly ) | Positive | 18 Mar 2020 | |||
Phase 2 | 24 | xqpoicqlcp(kesohieklx) = sofnpzikqm vjvkrojnai (jpusgphcww ) View more | Positive | 06 Nov 2018 | |||
Not Applicable | - | (lbcuafwszx) = vxasrfjemd jpwpliwgld (iwxxqrhuwb ) | - | 01 Oct 2014 | |||
Phase 2 | - | (PBMCs pulsed with HPV16 E6) | (qetwzecxjp) = Six patients had grade III toxicity (mainly anemia), which most likely is due to the disease kzorzugxvu (vijdnehnqy ) View more | - | 01 Jun 2005 |